Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Entropin, Inc. (NasdaqSC:ETOP)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs | Insider
Location
45926 Oasis Street
Indio, CA 92201
Phone: (760) 775-8333
Fax: (760) 775-1224
Email: lmuco@entropin.com
Employees (last reported count): 2
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 23%
·Over the last 6 months:
 · 3 insider buys; 3,000  shares (0.1% of insider shares)
·Institutional: 1% (1% of float)
(4 institutions)
·Net Inst. Selling: 58.0K shares (+485.00%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Entropin, Inc. is a development-stage pharmaceutical company that has developed Esterom, a topical formulation for the treatment of conditions involving impaired range of motion, which often accompanies injuries and disorders of the shoulder and lower back, as well as other conditions affecting body joints. Esterom is derived from a process involving the chemical breakdown of cocaine into new and different molecules, three of which have been patented by the Company. Entropin has completed four preclinical animal studies and Phase I and Phase II human clinical trials for Esterom. These trials indicated that Esterom was well tolerated and did not appear to have any potential for addiction or abuse.
More from Market Guide: Expanded Business Description

Financial Summary
Entropin, Inc. is a bio-pharmaceutical company developing a patented topical medicinal preparation effective in the treatment of impaired range of motion associated with acute lower back sprain and painful shoulder. For the six months ended 6/30/01, the Company reported no revenues. Net loss applicable to Common fell 32% to $1.8 million. Lower loss reflects reductions in general and administrative expenses and increased investment income.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Higgins Bailey, 70
Chairman
--  
Thomas Tachovsky, 54
Pres, CEO, Director
$220K
Patricia Kriss, 50
VP of Fin. and Admin., CFO
100K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:ETOPAs of 31-Aug-2001
Price and Volume
52-Week Low
on 2-Apr-2001
$1.531
Recent Price$2.06 
52-Week High
on 29-Sep-2000
$10.313
Beta1.27 
Daily Volume (3-month avg)8,000 
Daily Volume (10-day avg)10.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-78.0%
52-Week Change
relative to S&P500
-70.5%
Share-Related Items
Market Capitalization$20.0M
Shares Outstanding9.73M
Float7.50M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.68 
Earnings (ttm)-$0.45 
Earnings (mrq)-$0.13 
SalesN/A 
Cash (mrq)$1.05 
Valuation Ratios
Price/Book (mrq)3.03 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$5.01M
Income available to common (ttm)-$4.39M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-33.96%
Return on Equity (ttm)-53.79%
Financial Strength
Current Ratio (mrq)72.83 
Debt/Equity (mrq)0 
Total Cash (mrq)$10.2M
Short Interest
As of 8-Aug-2001
Shares Short11.0K
Percent of Float0.1%
Shares Short
(Prior Month)
23.0K
Short Ratio2.20 
Daily Volume5,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.